Cargando…
Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults—A randomized blinded controlled trial
BACKGROUND: Echinacea purpurea has clinical antiviral activity against respiratory viruses and modulates immune functions. In this study, we compared higher doses of new Echinacea formulations with conventional formulations at lower, preventive doses for therapy of respiratory tract infections (RTIs...
Autores principales: | Sumer, Johannes, Keckeis, Karin, Scanferla, Giulia, Frischknecht, Manuel, Notter, Julia, Steffen, Ana, Kohler, Philipp, Schmid, Patrick, Roth, Bianca, Wissel, Kerstin, Vernazza, Pietro, Klein, Peter, Schoop, Roland, Albrich, Werner C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150997/ https://www.ncbi.nlm.nih.gov/pubmed/37138742 http://dx.doi.org/10.3389/fmed.2023.948787 |
Ejemplares similares
-
Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial
por: Ogal, Mercedes, et al.
Publicado: (2021) -
Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Jawad, M., et al.
Publicado: (2012) -
Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial
por: Rauš, Karel, et al.
Publicado: (2015) -
Reduction of Viral Load in Patients with Acute Sore Throats: Results from an Observational Clinical Trial with Echinacea/Salvia Lozenges
por: Weishaupt, Ramon, et al.
Publicado: (2023) -
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2
por: Signer, Johanna, et al.
Publicado: (2020)